| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/03/2005 | US20050049184 Blood treatment using antibodies which bind to non-glycosylated leptin transport factor and/or to enzymes responsible for reducing blood concentrations of the glycosylated factor |
| 03/03/2005 | US20050049175 Use of neurotoxin therapy for treatment of urologic and related disorders related to urinary retention |
| 03/03/2005 | US20050048644 Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| 03/03/2005 | US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening |
| 03/03/2005 | US20050048129 Methods and compositions to aid breast enhancement |
| 03/03/2005 | US20050048128 Using ascorbic acid and petroleum jelly |
| 03/03/2005 | US20050048085 Exposure of infant mammal or bird to radiation detoxification lipopolysaccharide devived from microbial, fung al, protozoa endotoxin |
| 03/03/2005 | US20050048084 Therapy for bladder infections |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells |
| 03/03/2005 | US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke |
| 03/03/2005 | US20050048036 Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050048033 Using adipose stem cells to treat kidney and urogenital disorders; regenerative medicine |
| 03/03/2005 | US20050048032 Cell mixture comprising endocrine progenitor cells for use in treatment of diabetes; regenerative medicine and tissue engineering |
| 03/03/2005 | US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050048028 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 03/03/2005 | CA2848954A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 03/03/2005 | CA2536966A1 Use of enterococcus faecium strains for curing hepatic deficiency and for regenerating and intensifying hepatic metabolism in a liver |
| 03/03/2005 | CA2536495A1 Promoter of synoviolin gene |
| 03/03/2005 | CA2536492A1 Process for producing cytotoxic lymphocytes |
| 03/03/2005 | CA2535951A1 Bacterial strains, compositions including same and probiotic use thereof |
| 03/03/2005 | CA2535753A1 Neurogenin3 and production of pancreatic islet cells |
| 03/03/2005 | CA2535362A1 Lactic acid bacteria capable of stimulating mucosal immunity |
| 03/03/2005 | CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/03/2005 | CA2531022A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 03/03/2005 | CA2528292A1 A method for treating cancer patients undergoing chemotherapy |
| 03/03/2005 | CA2519337A1 Anti-cancer virus desensitization method |
| 03/03/2005 | CA2480236A1 Improved apparatus for the continuous separation of biological fluids into components and method of using same |
| 03/02/2005 | EP1510579A2 Use of heregulin as an epithelial cell growth factor |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509597A2 Hair follicle mesenchymal stem cells and use thereof |
| 03/02/2005 | EP1509594A1 Electrofusion of cells and apparatus therefore |
| 03/02/2005 | EP1509326A2 Method and apparatus for isolating platelets from blood |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509238A1 Calcium-containing composition from bone tissue |
| 03/02/2005 | EP1509087A2 Treatment for diabetes |
| 03/02/2005 | EP1509086A2 Htlv-i tax induced killing of p53 null cancer cells |
| 03/02/2005 | EP1282690B9 Isolation of precursor cells and their use for tissue repair |
| 03/02/2005 | EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 03/02/2005 | EP1137764B1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 03/02/2005 | EP1077698B1 Metabolites of ecteinascidin 743 |
| 03/02/2005 | EP1007965B1 Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| 03/02/2005 | EP0977881B1 Expression of a modified foamy virus envelope protein |
| 03/02/2005 | CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes |
| 03/02/2005 | CN1589150A Method for obtaining estrogens from mare's urine |
| 03/02/2005 | CN1589103A Nestin-expressing hair follicle stem cells |
| 03/02/2005 | CN1586501A Use of ground beetle in preparing medicine for treating virus infection disease |
| 03/02/2005 | CN1586500A Disodium cantharidinate injection for treating tumor and its preparing method |
| 03/02/2005 | CN1586499A Calf blood deproteinizing extract, its eye ointment preparation and its preparing method |
| 03/02/2005 | CN1586304A Instant donkey-hide gelatin mate |
| 03/02/2005 | CN1586299A Health tea |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/02/2005 | CN1191085C Ointment for treating burns, scalds and knife wound |
| 03/02/2005 | CN1191083C Eight-ingredient stomach-regulating oral liquid and preparing process thereof |
| 03/02/2005 | CN1191081C Psoriasis-treating ointment and its compounding process |
| 03/02/2005 | CN1191080C Plaster for treating facial neuritis and its preparing process |
| 03/02/2005 | CN1191079C Chinese medicine preparation for curing urinaemia |
| 03/02/2005 | CN1191077C Soluble granules for curing vitreous opacity and hemorrhage and preparation method thereof |
| 03/02/2005 | CN1191075C Composition and method for increasing weight gain and feed efficiency |
| 03/02/2005 | CN1191074C Bear bile powder eye drop and its prepn |
| 03/02/2005 | CN1191021C Method for working male frog products |
| 03/01/2005 | US6861506 Compositions and methods for the treatment and diagnosis of breast cancer |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 02/24/2005 | WO2005017165A1 Stem cell beacon |
| 02/24/2005 | WO2005017164A1 Vigilant cells |
| 02/24/2005 | WO2005017160A2 Mobilization of hematopoietic cells |
| 02/24/2005 | WO2005017132A1 Method of generating neural stem cells |
| 02/24/2005 | WO2005017131A2 Methods for the differentiation of human stem cells |
| 02/24/2005 | WO2005017115A2 Cord blood-derived hematopoietic progenitor cells |
| 02/24/2005 | WO2005017095A2 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | WO2005016373A1 Osteogenesis promoter |
| 02/24/2005 | WO2005016372A1 Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals |
| 02/24/2005 | WO2005016297A1 Hair regenerator |
| 02/24/2005 | WO2005016288A2 Methods and compositions for treatment of viral diseases |
| 02/24/2005 | WO2005016250A2 Cell therapy for neurometabolic disorders |
| 02/24/2005 | WO2005016245A2 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 02/24/2005 | WO2005016231A2 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/24/2005 | WO2005002494A3 Pharmaceutical active ingredient to combat prostatic cancer |
| 02/24/2005 | WO2004101762A3 Detection and treatment of cancers of the colon |
| 02/24/2005 | WO2004047620A3 Fixation method for bioprostheses |
| 02/24/2005 | WO2004015062A3 Methods and compositions relating to gene silencing |
| 02/24/2005 | US20050043788 Drug-eluting stent |
| 02/24/2005 | US20050043238 Exendin formulations for weight reduction |
| 02/24/2005 | US20050043216 Enamel matrix proteins administered topically as antineoplastic agents for ovarian, glandular, skin, muscle, or bone tumors. |
| 02/24/2005 | US20050043214 Antiglaucomatous agent and use thereof |
| 02/24/2005 | US20050042754 Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor |
| 02/24/2005 | US20050042749 Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
| 02/24/2005 | US20050042748 Methods for inducing differentiation of pluripotent cells |
| 02/24/2005 | US20050042746 Propagating sertoli cells in nutrient broth and generating and recovering tissue capable of assembly, propagation and maturation of afunctional artificial tissues; regenerative medicine and tissue engineering; treating diabetes |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042637 Pax-encoding vector and use thereof |
| 02/24/2005 | US20050042300 Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage |